Wolverine Trading, LLC Seres Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.15 $28,830 - $66,650	31,000 Added 149.76%	51,700 $72,000
Q3 2023 Nov 15, 2023	SELL	$2.33 - $5.07 $11,417 - $24,843	-4,900 Reduced 19.14%	20,700 $49,000
Q2 2023 Aug 23, 2023	BUY	$4.67 - $6.55 $119,552 - $167,680	25,600 New	25,600 $122,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.62 $29,700 - $83,820	11,000 New	11,000 $35,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $115,290 - $161,772	-18,300 Closed	0 $0

Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $39,732 - $75,438	6,600 Added 56.41%	18,300 $156,000
Q3 2021 Nov 12, 2021	SELL	$5.46 - $22.6 $57,876 - $239,560	-10,600 Reduced 47.53%	11,700 $80,000
Q2 2021 Aug 06, 2021	BUY	$18.46 - $24.36 $16,614 - $21,924	900 Added 4.21%	22,300 $533,000
Q1 2021 May 14, 2021	BUY	$17.66 - $28.92 $37,086 - $60,732	2,100 Added 10.88%	21,400 $416,000
Q4 2020 Feb 12, 2021	BUY	$23.25 - $37.73 $39,525 - $64,140	1,700 Added 9.66%	19,300 $507,000
Q3 2020 Nov 13, 2020	BUY	$3.74 - $28.74 $65,824 - $505,824	17,600 New	17,600 $506,000
Q4 2019 Feb 12, 2020	SELL	$2.99 - $4.42 $33,787 - $49,946	-11,300 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.29 - $4.16 $25,877 - $47,008	11,300 New	11,300 $44,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $86.9M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.